Related references
Note: Only part of the references are listed.2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia
Max Hamburger et al.
POSTGRADUATE MEDICINE (2012)
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Prevalence of Gout and Hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007-2008
Yanyan Zhu et al.
ARTHRITIS AND RHEUMATISM (2011)
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout
Sophie L. Stocker et al.
JOURNAL OF RHEUMATOLOGY (2011)
Frequency and risk factors of gout flares in a large population-based cohort of incident gout
Dietrich Rothenbacher et al.
RHEUMATOLOGY (2011)
Health Care Utilization in Patients with Gout
Jasvinder A. Singh et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Menopause, postmenopausal hormone use and risk of incident gout
A. Elisabeth Hak et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Diagnostic Rule for Acute Gouty Arthritis in Primary Care Without Joint Fluid Analysis
Hein J. E. M. Janssens et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Epidemiology of Gout in Women Fifty-two-Year Followup of a Prospective Cohort
Vidula Bhole et al.
ARTHRITIS AND RHEUMATISM (2010)
Variability Among Nonsteroidal Antiinflammatory Drugs in Risk of Upper Gastrointestinal Bleeding
Elvira L. Masso Gonzalez et al.
ARTHRITIS AND RHEUMATISM (2010)
High Versus Low Dosing of Oral Colchicine for Early Acute Gout Flare Twenty-Four-Hour Outcome of the First Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Comparison Colchicine Study
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2010)
The prevalence of rheumatic diseases in central Greece: a population survey
Ioannis Anagnostopoulos et al.
BMC MUSCULOSKELETAL DISORDERS (2010)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Clinical features of women with gout arthritis. A systematic review
K. J. M. Jansen Dirken-Heukensfeldt et al.
CLINICAL RHEUMATOLOGY (2010)
Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management
Virginie Montiel et al.
CLINICAL TOXICOLOGY (2010)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
A prescription for lifestyle change in patients with hyperuricemia and gout
Hyon K. Choi
CURRENT OPINION IN RHEUMATOLOGY (2010)
Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1
Daijiro Uetake et al.
INTERNAL MEDICINE (2010)
Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate
Promsuk Jutabha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Update on gout: new therapeutic strategies and options
Robert Terkeltaub
NATURE REVIEWS RHEUMATOLOGY (2010)
Metabolic Syndrome Characteristics in Gout Patients
J. M. Fraile et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2010)
Prescription and comorbidity screening following consultation for acute gout in primary care
Edward Roddy et al.
RHEUMATOLOGY (2010)
Gout: an independent risk factor for all-cause and cardiovascular mortality
Chang-Fu Kuo et al.
RHEUMATOLOGY (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
Gout, Hyperuricemia, and the Risk of Cardiovascular Disease: Cause and Effect?
Ankoor Shah et al.
Current Rheumatology Reports (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Opportunities for improving medication use and monitoring in gout
J. A. Singh et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
M. K. Reinders et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Hyperuricemia and Risk of Stroke: A Systematic Review and Meta-Analysis
Seo Young Kim et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Serum Uric Acid Level as an Independent Risk Factor for All-Cause, Cardiovascular, and Ischemic Stroke Mortality: A Chinese Cohort Study
Jiunn-Horng Chen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
The gout diagnosis
R. K. DORE
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum
Sian E. Williams et al.
HUMAN MOLECULAR GENETICS (2009)
Short Term Treatment With Clarithromycin Resulting in Colchicine-Induced Rhabdomyolysis
James McKinnell et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
The Effect of Serum Urate on Gout Flares and Their Associated Costs An Administrative Claims Analysis
Rachel Halpern et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Clinical Diagnostic Criteria for Gout Comparsion With the Gold Standard of Synovial Fluid Crystal Analysis
Aarti Malik et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
First Acute Gout Attacks Commonly Precede Features of the Metabolic Syndrome
Claudia Berenice Hernandez-Cuevas et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Serum Urate During Acute Gout
Naomi Schlesinger et al.
JOURNAL OF RHEUMATOLOGY (2009)
Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
Michael A. Becker et al.
JOURNAL OF RHEUMATOLOGY (2009)
Quality of Life and Disability in Patients with Treatment-Failure Gout
Michael A. Becker et al.
JOURNAL OF RHEUMATOLOGY (2009)
Frequency, Risk, and Cost of Gout-related Episodes Among the Elderly: Does Serum Uric Acid Level Matter?
Eric Q. Wu et al.
JOURNAL OF RHEUMATOLOGY (2009)
Potentially fatal interaction between colchicine and disulfiram
Shu-Chiao Chen et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
H. R. Schumacher et al.
RHEUMATOLOGY (2009)
Treating to target: a strategy to cure gout
Fernando Perez-Ruiz
RHEUMATOLOGY (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Adherence to Urate-Lowering Therapy
Richard O. Day
SOUTHERN MEDICAL JOURNAL (2009)
Novel therapies for treatment of gout and hyperuricemia
Robert Terkeltaub
ARTHRITIS RESEARCH & THERAPY (2009)
Adherence with urate-lowering therapies for the treatment of gout
Leslie R. Harrold et al.
ARTHRITIS RESEARCH & THERAPY (2009)
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout
Jeannie Chao et al.
Current Rheumatology Reports (2009)
Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patients
Toshihiro Hamada et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Long-term cardiovascular mortality among middle-aged men with gout
Eswar Krishnan et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease
Adriana G. Ioachimescu et al.
ARTHRITIS AND RHEUMATISM (2008)
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout - Results of a phase II randomized study
John S. Sundy et al.
ARTHRITIS AND RHEUMATISM (2008)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Serum uric acid and risk of cardiovascular mortality: A prospective long-term study of 83 683 Austrian men
Alexander Strasak et al.
CLINICAL CHEMISTRY (2008)
Plasma uric acid and the risk of type 2 diabetes in a Chinese community
Kuo-Liong Chien et al.
CLINICAL CHEMISTRY (2008)
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects
Sophie L. Stocker et al.
CLINICAL PHARMACOKINETICS (2008)
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials
Paul A. Scott et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study
Alexander M. Strasak et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Elevated Uric Acid Increases the Risk for Kidney Disease
Rudolf P. Obermayr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
Hein J. E. M. Janssens et al.
LANCET (2008)
Serum Uric Acid and Components of the Metabolic Syndrome in Non-Diabetic Populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China
Hairong Nan et al.
Metabolic Syndrome and Related Disorders (2008)
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy
Michael A. Becker et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Comparison of drug adherence rates among patients with seven different medical conditions
Becky A. Briesacher et al.
PHARMACOTHERAPY (2008)
Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile
H. K. Choi et al.
RHEUMATOLOGY (2008)
GRADE:: going from evidence to recommendations
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
L. Annemans et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Predictors of new-onset decline in kidney function in a general middle-european population
Rudolf P. Obermayr et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes
Abbas Dehghan et al.
DIABETES CARE (2008)
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Rapid onset of muscle weakness (Rhabdomyolysis) associated with the combined use of simvastatin and colchicine
Maria Justiniano et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2007)
Plasma urate and risk of Parkinson's disease
M. G. Weisskopf et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Manifestations of metabolic syndrome associated with male gout in different age strata
Shih-Yang Chen et al.
CLINICAL RHEUMATOLOGY (2007)
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients
Mattheus K. Reinders et al.
CLINICAL RHEUMATOLOGY (2007)
Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency
Rosa J. Torres et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout
Eliseo Pascual et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial
Joshua F. Baker et al.
ANGIOLOGY (2007)
Quality of care for gout in the US needs improvement
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Impact of sonography in gouty arthritis: Comparison with conventional radiography, clinical examination, and laboratory findings
Claudia Schueller-Weidekamm et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: A double-blind, randomized, controlled trial
Chi Yin Man et al.
ANNALS OF EMERGENCY MEDICINE (2007)
Hyperuricemia and incidence of hypertension among men without metabolic syndrome
Eswar Krishnan et al.
HYPERTENSION (2007)
Plasma uric acid level and risk for incident hypertension among men
John P. Forman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study
A. Shankar et al.
JOURNAL OF HUMAN HYPERTENSION (2006)
Uric acid and the development of hypertension - The normative aging study
Todd S. Perlstein et al.
HYPERTENSION (2006)
Serum uric acid predicts incident hypertension in a biethnic cohort - The atherosclerosis risk in communities study
Philip B. Mellen et al.
HYPERTENSION (2006)
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials
Jingjing Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
EULAR evidence based recommendations for gout.: Part I:: Diagnosis.: Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Serum uric acid and multiple sclerosis
M. Rentzos et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2006)
Rhabdomyolysis in a patient treated with colchicine and atorvastatin
Abdurrahman Tufan et al.
ANNALS OF PHARMACOTHERAPY (2006)
Gout medication treatment patterns and adherence to standards of care from a managed care perspective
CA Sarawate et al.
MAYO CLINIC PROCEEDINGS (2006)
Serum urate levels and gout flares - Analysis from managed care data
CA Sarawate et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)
Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance -: The Finnish diabetes prevention study
L Niskanen et al.
DIABETES CARE (2006)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
R Khosravan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The prevalence of metabolic syndrome in patients with gout : A multicenter study
YH Rho et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)
TR Mikuls et al.
RHEUMATOLOGY (2005)
Acute myopathy in a patient with concomitant use of pravastatin and colchicine
G Alayli et al.
ANNALS OF PHARMACOTHERAPY (2005)
Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study
HK Choi et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Share Paper
